Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells
- 29 November 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (55) , 7925-7934
- https://doi.org/10.1038/sj.onc.1204990
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 26 references indexed in Scilit:
- STAT proteins: novel molecular targets for cancer drug discoveryOncogene, 2000
- Constitutive Activation of Stat 3 Oncogene Product in Human Ovarian Carcinoma CellsGynecologic Oncology, 2000
- STATs in oncogenesisOncogene, 2000
- STAT signaling in head and neck cancerOncogene, 2000
- Functional Roles of STAT Family Proteins: Lessons from Knockout MiceThe International Journal of Cell Cloning, 1999
- Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cellsLeukemia, 1999
- Bcl-xLIs Expressed in Ovarian Carcinoma and Modulates Chemotherapy-Induced ApoptosisGynecologic Oncology, 1998
- JAKs and STATs branch outTrends in Cell Biology, 1996
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996
- Stat3: a STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Interleukin-6Science, 1994